BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18545772)

  • 1. Working memory in Parkinson's disease patients: clinical features and response to levodopa.
    Beato R; Levy R; Pillon B; Vidal C; du Montcel ST; Deweer B; Bonnet AM; Houeto JL; Dubois B; Cardoso F
    Arq Neuropsiquiatr; 2008 Jun; 66(2A):147-51. PubMed ID: 18545772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Parkinson's disease and dopamine on digit span measures of working memory.
    Grogan JP; Knight LE; Smith L; Irigoras Izagirre N; Howat A; Knight BE; Bickerton A; Isotalus HK; Coulthard EJ
    Psychopharmacology (Berl); 2018 Dec; 235(12):3443-3450. PubMed ID: 30315362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociable effects of dopaminergic therapy on spatial versus non-spatial working memory in Parkinson's disease.
    Mollion H; Ventre-Dominey J; Dominey PF; Broussolle E
    Neuropsychologia; 2003; 41(11):1442-51. PubMed ID: 12849762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levodopa medication improves incidental sequence learning in Parkinson's disease.
    Beigi M; Wilkinson L; Gobet F; Parton A; Jahanshahi M
    Neuropsychologia; 2016 Dec; 93(Pt A):53-60. PubMed ID: 27686948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficit of short-term memory in newly diagnosed untreated parkinsonian patients: reversal after L-dopa therapy.
    Marini P; Ramat S; Ginestroni A; Paganini M
    Neurol Sci; 2003 Oct; 24(3):184-5. PubMed ID: 14598078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alpha2 agonist, clonidine, improves spatial working performance in Parkinson's disease.
    Riekkinen M; Jäkälä P; Kejonen K; Riekkinen P
    Neuroscience; 1999; 92(3):983-9. PubMed ID: 10426538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of levodopa on corticostriatal circuits supporting working memory in Parkinson's disease.
    Simioni AC; Dagher A; Fellows LK
    Cortex; 2017 Aug; 93():193-205. PubMed ID: 28675834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of clinical motor variables and medication dosage on working memory in Parkinson's disease.
    Moustafa AA; Bell P; Eissa AM; Hewedi DH
    Brain Cogn; 2013 Jul; 82(2):137-45. PubMed ID: 23660434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. At which steps of spatial working memory processing do striatofrontal circuits intervene in humans?
    Le Bras C; Pillon B; Damier P; Dubois B
    Neuropsychologia; 1999 Jan; 37(1):83-90. PubMed ID: 9920474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease.
    Lewis SJ; Slabosz A; Robbins TW; Barker RA; Owen AM
    Neuropsychologia; 2005; 43(6):823-32. PubMed ID: 15716155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Parkinson's disease and dopaminergic medication on proprioceptive processing.
    Mongeon D; Blanchet P; Messier J
    Neuroscience; 2009 Jan; 158(2):426-40. PubMed ID: 18996173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory for spatial location is affected in Parkinson's disease.
    Pillon B; Ertle S; Deweer B; Sarazin M; Agid Y; Dubois B
    Neuropsychologia; 1996 Jan; 34(1):77-85. PubMed ID: 8852695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine supports sentence comprehension in Parkinson's Disease.
    Grossman M; Glosser G; Kalmanson J; Morris J; Stern MB; Hurtig HI
    J Neurol Sci; 2001 Mar; 184(2):123-30. PubMed ID: 11239945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. It's all in the type of the task: Dopamine modulates kinematic patterns during competitive vs. cooperative interaction in Parkinson's disease.
    Straulino E; Scaravilli T; Bulgheroni M; D'Amico E; Castiello U
    Neuropsychologia; 2016 Dec; 93(Pt A):106-115. PubMed ID: 27756693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial and non-spatial working memory at different stages of Parkinson's disease.
    Owen AM; Iddon JL; Hodges JR; Summers BA; Robbins TW
    Neuropsychologia; 1997 Apr; 35(4):519-32. PubMed ID: 9106280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
    Parkinson Study Group
    JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic modulation of visual-spatial working memory in Parkinson's disease.
    Costa A; Peppe A; Dell'Agnello G; Carlesimo GA; Murri L; Bonuccelli U; Caltagirone C
    Dement Geriatr Cogn Disord; 2003; 15(2):55-66. PubMed ID: 12566593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa and executive performance in Parkinson's disease: a randomized study.
    Pascual-Sedano B; Kulisevsky J; Barbanoj M; García-Sánchez C; Campolongo A; Gironell A; Pagonabarraga J; Gich I
    J Int Neuropsychol Soc; 2008 Sep; 14(5):832-41. PubMed ID: 18764978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractionating the Neurocognitive Mechanisms Underlying Working Memory: Independent Effects of Dopamine and Parkinson's Disease.
    Fallon SJ; Mattiesing RM; Muhammed K; Manohar S; Husain M
    Cereb Cortex; 2017 Dec; 27(12):5727-5738. PubMed ID: 29040416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal ganglia, Parkinson's disease and levodopa therapy. Proceedings of a meeting. St Thomas, Virgin Islands, January 2000.
    Trends Neurosci; 2000 Oct; 23(10 Suppl):S1-126. PubMed ID: 11221749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.